Novel Gene Polymorphisms for Stable Warfarin Dose in a Korean Population: Genome-Wide Association Study

Warfarin has a narrow therapeutic window and high intra- and inter-individual variability. Considering that many published papers on genotype-guided dosing are derived from European populations, the aim of this study was to investigate novel genetic variants associated with the variability of stable...

Full description

Bibliographic Details
Main Authors: Jung Sun Kim, Sak Lee, Jeong Yee, Kyemyung Park, Eun Jeong Jang, Byung Chul Chang, Hye Sun Gwak
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Series:Biomedicines
Subjects:
Online Access:https://www.mdpi.com/2227-9059/11/8/2308
_version_ 1797406252285820928
author Jung Sun Kim
Sak Lee
Jeong Yee
Kyemyung Park
Eun Jeong Jang
Byung Chul Chang
Hye Sun Gwak
author_facet Jung Sun Kim
Sak Lee
Jeong Yee
Kyemyung Park
Eun Jeong Jang
Byung Chul Chang
Hye Sun Gwak
author_sort Jung Sun Kim
collection DOAJ
description Warfarin has a narrow therapeutic window and high intra- and inter-individual variability. Considering that many published papers on genotype-guided dosing are derived from European populations, the aim of this study was to investigate novel genetic variants associated with the variability of stable warfarin dose in the Korean population with cardiac valve replacement, using the GWAS approach. This retrospective cohort study was performed from January 1982 to December 2020 at the Severance Cardiovascular Hospital of Yonsei University College of Medicine. GWAS was performed to identify associations between genotypes and the warfarin maintenance dose, by comparing the allele frequency of genetic variants between individuals. Then, the extent of genetic and non-genetic factors on the dose variability was determined by multivariable regression analysis. The study enrolled 214 participants, and the most robust signal cluster was detected on chromosome 16 around <i>VKORC1.</i> Followed by <i>VKORC1</i>, three novel variants (<i>NKX2-6</i> rs310279, <i>FRAS1</i> rs4386623, and <i>FAM201A</i> rs1890109) showed an association with stable warfarin dose requirement in univariate analysis. The algorithm was constructed by using multivariable analysis that includes genetic and non-genetic factors, and it could explain 58.5% of the variations in stable warfarin doses. In this variability, <i>VKORC1</i> rs9934438 and <i>FRAS1</i> rs4386623 accounted for 33.0% and 9.9%, respectively. This GWAS analysis identified the fact that three novel variants (<i>NKX2-6</i> rs310279, <i>FRAS1</i> rs4386623, and <i>FAM201A</i> rs1890109) were associated with stable warfarin doses. Additional research is necessary to validate the results and establish personalized treatment strategies for the Korean population.
first_indexed 2024-03-09T03:22:42Z
format Article
id doaj.art-a53db97e8ef4471cbe945c0002056a61
institution Directory Open Access Journal
issn 2227-9059
language English
last_indexed 2024-03-09T03:22:42Z
publishDate 2023-08-01
publisher MDPI AG
record_format Article
series Biomedicines
spelling doaj.art-a53db97e8ef4471cbe945c0002056a612023-12-03T15:06:36ZengMDPI AGBiomedicines2227-90592023-08-01118230810.3390/biomedicines11082308Novel Gene Polymorphisms for Stable Warfarin Dose in a Korean Population: Genome-Wide Association StudyJung Sun Kim0Sak Lee1Jeong Yee2Kyemyung Park3Eun Jeong Jang4Byung Chul Chang5Hye Sun Gwak6Graduate School of Pharmaceutical Sciences, College of Pharmacy, Ewha Womans University, Seoul 03760, Republic of KoreaDepartment of Thoracic and Cardiovascular Surgery, Cardiovascular Research Institute, Yonsei University College of Medicine, Seoul 03722, Republic of KoreaGraduate School of Pharmaceutical Sciences, College of Pharmacy, Ewha Womans University, Seoul 03760, Republic of KoreaDepartment of Biomedical Engineering, College of Information and Biotechnology, Ulsan National Institute of Science and Technology, Ulsan 44919, Republic of KoreaGraduate School of Pharmaceutical Sciences, College of Pharmacy, Ewha Womans University, Seoul 03760, Republic of KoreaDepartment of Thoracic and Cardiovascular Surgery, Cardiovascular Research Institute, Yonsei University College of Medicine, Seoul 03722, Republic of KoreaGraduate School of Pharmaceutical Sciences, College of Pharmacy, Ewha Womans University, Seoul 03760, Republic of KoreaWarfarin has a narrow therapeutic window and high intra- and inter-individual variability. Considering that many published papers on genotype-guided dosing are derived from European populations, the aim of this study was to investigate novel genetic variants associated with the variability of stable warfarin dose in the Korean population with cardiac valve replacement, using the GWAS approach. This retrospective cohort study was performed from January 1982 to December 2020 at the Severance Cardiovascular Hospital of Yonsei University College of Medicine. GWAS was performed to identify associations between genotypes and the warfarin maintenance dose, by comparing the allele frequency of genetic variants between individuals. Then, the extent of genetic and non-genetic factors on the dose variability was determined by multivariable regression analysis. The study enrolled 214 participants, and the most robust signal cluster was detected on chromosome 16 around <i>VKORC1.</i> Followed by <i>VKORC1</i>, three novel variants (<i>NKX2-6</i> rs310279, <i>FRAS1</i> rs4386623, and <i>FAM201A</i> rs1890109) showed an association with stable warfarin dose requirement in univariate analysis. The algorithm was constructed by using multivariable analysis that includes genetic and non-genetic factors, and it could explain 58.5% of the variations in stable warfarin doses. In this variability, <i>VKORC1</i> rs9934438 and <i>FRAS1</i> rs4386623 accounted for 33.0% and 9.9%, respectively. This GWAS analysis identified the fact that three novel variants (<i>NKX2-6</i> rs310279, <i>FRAS1</i> rs4386623, and <i>FAM201A</i> rs1890109) were associated with stable warfarin doses. Additional research is necessary to validate the results and establish personalized treatment strategies for the Korean population.https://www.mdpi.com/2227-9059/11/8/2308warfarin<i>FRAS1</i><i>FAM201A</i><i>NKX2-6</i>polymorphismGWAS
spellingShingle Jung Sun Kim
Sak Lee
Jeong Yee
Kyemyung Park
Eun Jeong Jang
Byung Chul Chang
Hye Sun Gwak
Novel Gene Polymorphisms for Stable Warfarin Dose in a Korean Population: Genome-Wide Association Study
Biomedicines
warfarin
<i>FRAS1</i>
<i>FAM201A</i>
<i>NKX2-6</i>
polymorphism
GWAS
title Novel Gene Polymorphisms for Stable Warfarin Dose in a Korean Population: Genome-Wide Association Study
title_full Novel Gene Polymorphisms for Stable Warfarin Dose in a Korean Population: Genome-Wide Association Study
title_fullStr Novel Gene Polymorphisms for Stable Warfarin Dose in a Korean Population: Genome-Wide Association Study
title_full_unstemmed Novel Gene Polymorphisms for Stable Warfarin Dose in a Korean Population: Genome-Wide Association Study
title_short Novel Gene Polymorphisms for Stable Warfarin Dose in a Korean Population: Genome-Wide Association Study
title_sort novel gene polymorphisms for stable warfarin dose in a korean population genome wide association study
topic warfarin
<i>FRAS1</i>
<i>FAM201A</i>
<i>NKX2-6</i>
polymorphism
GWAS
url https://www.mdpi.com/2227-9059/11/8/2308
work_keys_str_mv AT jungsunkim novelgenepolymorphismsforstablewarfarindoseinakoreanpopulationgenomewideassociationstudy
AT saklee novelgenepolymorphismsforstablewarfarindoseinakoreanpopulationgenomewideassociationstudy
AT jeongyee novelgenepolymorphismsforstablewarfarindoseinakoreanpopulationgenomewideassociationstudy
AT kyemyungpark novelgenepolymorphismsforstablewarfarindoseinakoreanpopulationgenomewideassociationstudy
AT eunjeongjang novelgenepolymorphismsforstablewarfarindoseinakoreanpopulationgenomewideassociationstudy
AT byungchulchang novelgenepolymorphismsforstablewarfarindoseinakoreanpopulationgenomewideassociationstudy
AT hyesungwak novelgenepolymorphismsforstablewarfarindoseinakoreanpopulationgenomewideassociationstudy